Enento Group Oyj (HEL:ENENTO)

CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	368	414	463	514	793	807
Market Cap Growth	3.62%	-10.71%	-9.92%	-35.15%	-1.67%	6.73%
Enterprise Value	513	551	609	658	944	947
Last Close Price	15.54	16.95	17.89	18.50	27.55	27.30
PE Ratio	37.15	34.04	26.38	29.64	30.66	41.48
Forward PE	17.22	17.70	16.80	17.78	24.81	26.53
PS Ratio	2.44	2.75	2.97	3.07	4.85	5.33
PB Ratio	1.41	1.57	1.64	1.74	2.51	2.56
P/FCF Ratio	11.75	12.83	13.11	11.52	18.74	20.18
P/OCF Ratio	11.68	12.67	12.59	11.48	18.05	19.72
PEG Ratio	2.00	3.68	3.68	3.68	3.68	3.68
EV/Sales Ratio	3.40	3.66	3.91	3.93	5.77	6.26
EV/EBITDA Ratio	15.43	16.05	16.06	13.24	19.42	21.97
EV/EBIT Ratio	19.77	18.83	18.68	17.86	27.06	31.76
EV/FCF Ratio	16.40	17.07	17.23	14.73	22.31	23.70
Debt / Equity Ratio	0.59	0.59	0.56	0.52	0.53	0.54
Debt / EBITDA Ratio	4.59	4.18	3.90	2.91	3.27	3.73
Debt / FCF Ratio	4.93	4.78	4.44	3.42	3.94	4.24
Asset Turnover	0.32	0.32	0.32	0.32	0.30	0.28
Quick Ratio	1.10	0.88	1.06	1.18	1.22	1.15
Current Ratio	1.10	1.15	1.27	1.44	1.44	1.32
Return on Equity (ROE)	3.69%	4.45%	6.08%	5.68%	8.19%	6.22%
Return on Assets (ROA)	3.53%	3.85%	4.12%	4.42%	3.98%	3.40%
Return on Capital (ROIC)	3.92%	4.26%	4.59%	4.95%	4.51%	3.87%
Return on Capital Employed (ROCE)	6.20%	6.80%	7.20%	7.90%	6.90%	5.80%
Earnings Yield	2.67%	2.94%	3.79%	3.37%	3.26%	2.41%
FCF Yield	8.51%	7.80%	7.63%	8.68%	5.34%	4.95%
Dividend Yield	6.44%	5.90%	5.59%	5.40%	3.63%	3.48%
Payout Ratio	240.66%	194.96%	136.85%	138.59%	88.26%	117.27%
Buyback Yield / Dilution	2.09%	0.77%	0.60%	-0.03%	-0.04%	-0.07%
Total Shareholder Return	8.54%	6.67%	6.19%	5.38%	3.59%	3.41%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.